Evolent Health, Inc.
EVH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,555 | $1,964 | $1,352 | $908 |
| % Growth | 30.1% | 45.3% | 48.9% | – |
| Cost of Goods Sold | $2,187 | $1,503 | $1,035 | $658 |
| Gross Profit | $367 | $460 | $317 | $250 |
| % Margin | 14.4% | 23.4% | 23.4% | 27.6% |
| R&D Expenses | $0 | $0 | $27 | $0 |
| G&A Expenses | $0 | $0 | $0 | $219 |
| SG&A Expenses | $263 | $358 | $269 | $219 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $145 | $174 | $17 | $73 |
| Operating Expenses | $408 | $532 | $313 | $293 |
| Operating Income | -$40 | -$71 | $4 | -$42 |
| % Margin | -1.6% | -3.6% | 0.3% | -4.7% |
| Other Income/Exp. Net | -$23 | -$131 | -$66 | $13 |
| Pre-Tax Income | -$63 | -$202 | -$62 | -$30 |
| Tax Expense | -$1 | -$89 | -$43 | $0 |
| Net Income | -$62 | -$113 | -$19 | -$38 |
| % Margin | -2.4% | -5.8% | -1.4% | -4.1% |
| EPS | -0.81 | -1.28 | -0.2 | -0.36 |
| % Growth | 36.7% | -540% | 44.4% | – |
| EPS Diluted | -0.81 | -1.28 | -0.2 | -0.36 |
| Weighted Avg Shares Out | 115 | 111 | 94 | 86 |
| Weighted Avg Shares Out Dil | 115 | 111 | 94 | 86 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $5 | $1 | $0 |
| Interest Expense | $25 | $54 | $16 | $25 |
| Depreciation & Amortization | $123 | $123 | $90 | $60 |
| EBITDA | $85 | -$25 | $44 | $56 |
| % Margin | 3.3% | -1.3% | 3.2% | 6.1% |